Allurion Technologies (ALURW) Operating Margin (2022 - 2026)
Allurion Technologies (ALURW) reported Operating Margin of 126.6% for Q1 2026, up 390.0% on a YoY basis from 25.84% in Q1 2025, and up 27.32% quarter-over-quarter from 174.2% in Q4 2025.
Allurion Technologies (ALURW) Operating Margin (2022 - 2026) Analysis & Trends
Allurion Technologies has reported Operating Margin for 5 years, with the latest figure at 126.6% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin rose 390.0% year-over-year to 126.6%; the trailing twelve-month figure through Mar 2026 stood at 211.22% (down 4840.0% YoY), and the FY2025 full-year result was 198.01%, down 4168.0% from the prior year.
- Operating Margin for Q1 2026 stood at 126.6%, up from 174.2% in the prior quarter.
- The five-year high for Operating Margin was 26.42% in Q2 2022, with the low at 362.3% in Q3 2025.
- Historically, Operating Margin has averaged 159.26% across 5 years, with a median of 128.55% in 2026.
- Annual changes were most pronounced in 2023 — Operating Margin tumbled 26013 bps — and 2025, when it surged 13191 bps.
- Allurion Technologies' Operating Margin stood at 52.9% in 2022, then plunged by 492 bps to 313.03% in 2023, then advanced by 2 bps to 306.12% in 2024, then soared by 43 bps to 174.2% in 2025, then rose by 27 bps to 126.6% in 2026.
- The last three Operating Margin figures came in at 126.6% (Q1 2026), 174.2% (Q4 2025), and 362.3% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Allurion Technologies | - | - | 1.23 Mn | -126.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126.60% |
| Dec 31, 2025 | -174.20% |
| Sep 30, 2025 | -362.30% |
| Jun 30, 2025 | -205.74% |
| Mar 31, 2025 | -130.50% |
| Dec 31, 2024 | -306.12% |
| Sep 30, 2024 | -229.94% |
| Jun 30, 2024 | -79.43% |
| Mar 31, 2024 | -121.35% |
| Dec 31, 2023 | -313.03% |
| Sep 30, 2023 | -143.70% |
| Jun 30, 2023 | -102.58% |
| Mar 31, 2023 | -98.72% |
| Dec 31, 2022 | -52.90% |
| Sep 30, 2022 | -74.61% |
| Jun 30, 2022 | -26.42% |